Found 9 matching trials
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
PHASE4* There is a knowledge gap associated with the management of patients with ...
Location
Cedars-Sinai Medical Center
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
PHASE3This study will evaluate if extended therapy with oral rivaroxaban can prev...
Location
Multiple Locations
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
PHASE3The purpose of this study is to learn whether apixaban prevents the develop...
Location
Local Institution
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
PHASE2The purpose of this study is to determine the efficacy of JNJ-70033093 in p...
Location
Central Research Associates, Inc.
Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
PHASE4The RIGHT study is a large randomized study dedicated to post-PPCI anticoag...
Location
Beijing Anzhen Hospital, Capital Medical University
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
PHASE3In a 2x2 factorial design randomized controlled trial, the investigators ai...
Location
Masih Daneshvari Hospital
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
PHASE3The purpose of this study is to learn whether apixaban can prevent the bloo...
Location
Capstone Clinical Trials, Inc
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
PHASE2The primary objective of this study is to establish the dose-response relat...
Location
1160.19.43004 Krankenhaus der Barmherzigen Schwestern Linz
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
PHASE3Objectives are to evaluate whether idrabiotaparinux sodium (SSR126517E) is ...
Location
Sanofi-Aventis Administrative Office